The story of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in sales , its exclusivity period created a flood of https://one-bookmark.com/story21345033/sildenafil-and-the-pharmaceutical-sector-a-risky-investment